<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="/images/favicon.png" type="image/x-icon">
  <title>Kawasaki Disease</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>
      
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


    <h1>Kawasaki Disease</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <div class="outline2">

      <input type="radio" name="control-2" id="show-2">
      <label for="show-2">Show Outline</label>
      <input type="radio" name="control-2" id="hide-2">
      <label for="hide-2">Hide Outline</label>
      <div class="contents">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Etiology</a></li>
            <li><a href="#header-3">Epidemiology</a></li>
            <li><a href="#header-4">Pathogenesis</a></li>
            <li><a href="#header-5">Clinical Manifestations</a></li>
            <ul>
                <li><a href="#heading-5-1">Subacute Phase</a></li>
                <li><a href="#heading-5-2">Convalescent Phase</a></li>
            </ul>
            <li><a href="#header-6">Laboratory and Imaging Studies</a></li>
            <ul>
                <li><a href="#heading-6-1">Criteria for Diagnosis of Kawasaki Disease</a></li>
            </ul>
            <li><a href="#header-7">Treatment</a></li>
            <li><a href="#header-8">Complications of Kawasaki Disease</a></li>
            <li><a href="#header-9">Differential Diagnosis of Kawasaki Disease</a></li>
            <li><a href="#header-10">Prognosis</a></li>
         </ol>
      </div>
     <div>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <p>KD is a vasculitis of unknown etiology that is characterized by multisystem involvement and inflammation of small to medium-sized arteries with resulting aneurysm formation.</p>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Etiology</a>
          </h2>
        </header>
        <div class='body'>
            
            <ul>
                <li>The cause of the illness remains unknown, but clinical and epidemiologic features strongly support an infectious origin.</li>
                <li>One hypothesis is that a ubiquitous agent causes Kawasaki disease and that symptomatic illness occurs only in genetically predisposed hosts.</li>
                <li>The infrequent occurrence of the illness in infants younger than 4 mo may be due to passive maternal antibody, and the virtual absence of cases in adults may be due to widespread immunity.</li>
            </ul>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Can affect children of all races, but more common among children of Asian descent.</li>
                <li>Most common in children younger than age 5, with a peak between ages 2 and 3 years, and is rare in children older than age 7.</li>
                <li>A seasonal variability has been described with a peak between February and May</li>
            </ul>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathogenesis</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Kawasaki disease causes a severe vasculitis of all blood vessels but predominantly affecting the medium-sized arteries, with predilection for the coronary arteries.</li>
                <li>In the acute or subacute stages - edema of endothelial and smooth muscle cells with intense inflammatory infiltration of the vascular wall, initially by polymorphonuclear cells but rapidly changing to macrophages, lymphocytes, and plasma cells. IgA plasma cells are prominent in the inflammatory infiltrate.</li>
                <li>In the most severely affected vessels, inflammation involves all three layers of the vascular wall, with destruction of the internal elastic lamina. The vessel loses its structural integrity and weakens, resulting in dilatation or aneurysm formation.</li>
                <li>Thrombi may form in the lumen and obstruct blood flow.</li>
                <li>In the healing phase, the lesion becomes progressively fibrotic, with marked intimal proliferation, which may result in stenotic occlusion of the vessel over time. Those are the major factors leading to coronary disease.</li>
            </ul>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Manifestations</a>
          </h2>
        </header>
        <div class='body'>
            <p>The clinical course of KD can be divided into three phases, each with its own unique manifestations. Aneurysmal involvement of the coronary arteries is the most important manifestation of KD.</p>

            <section id='heading-5-1'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-5-1'>Acute Phase</a>
                </h3>
              </header>
              <div class='body'>
                 <ul>
                  <li>(1 to 2 weeks)</li>
                  <li>Sudden onset of a high, hectic fever (‚â•40¬∞C) without an apparent source.</li>
                  <li>The onset of fever is followed by conjunctival erythema; mucosal changes, including dry, cracked lips and a strawberry tongue; cervical lymphadenopathy; and swelling of the hands and feet. The conjunctivitis is bilateral and nonsuppurative.</li>
                  <li>A rash, which can vary in appearance, occurs in 80% of children with KD and may be particularly accentuated in the inguinal area and on the chest.</li>
                  <li>Extreme irritability is prominent, especially in infants.</li>
                  <li>Abdominal pain and hydrops of the gallbladder, CSF pleocytosis, and arthritis, particularly of medium-sized to large joints, can arise.</li>
                  <li>Carditis in the acute phase may be manifested by tachycardia, shortness of breath, or overt congestive heart failure. Giant coronary artery aneurysms, which are rare but occur most commonly in very young children, can appear during this phase.</li>
                 </ul>
              </div>
            </section>

            <section id='heading-5-2'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-5-2'>Subacute Phase</a>
                </h3>
              </header>
              <div class='body'>
                 <ul>
                  <li>Lasts until about the fourth week</li>
                  <li>Gradual resolution of fever (if untreated) and other symptoms. Desquamation of the skin, particularly of the fingers and toes, appears at this point.</li>
                  <li>The platelet count, previously normal or slightly elevated, increases to a significant degree (often >1 million/mm3).</li>
                  <li>This phase heralds the onset of coronary artery aneurysms, which usually appear in the subacute and convalescent phases, and pose the highest risk of sudden death.</li>
                 </ul>
              </div>
            </section>

            <section id='heading-5-3'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-5-3'>Convalescent Phase</a>
                </h3>
              </header>
              <div class='body'>
                 <ul>
                  <li>The convalescent phase begins with the disappearance of clinical symptoms and continues until the ESR returns to normal, usually 6 to 8 weeks after the onset of illness. </li>
                  <li>Beau lines of the fingernails may appear during this phase.</li>
                 </ul>

                 
              </div>
            </section>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Laboratory and Imaging Studies</a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>Blood cultures</li>
            <li>Urine cultures</li>
            <li>Chest x-ray.</li>
            <li>In the acute phase parameters are elevated, including WBC count, platelet count, and the ESR, which can be profoundly elevated (often >80 mm/hr).</li>
            <li>A lumbar puncture-may show pleocytosis.</li>
            <li>Tests of hepatobiliary function may be abnormal. Greatly elevated platelet counts develop during the subacute phase.</li>
            <li>Two-dimensional echocardiograms, usually during the acute phase, at 2 to 3 weeks, and at 6 to 8 weeks. More frequent echocardiograms and, potentially, coronary angiography are indicated for patients who develop coronary artery abnormalities.</li>
           </ul>
          <section id='heading-6-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-1'>Criteria for Diagnosis of Kawasaki Disease</a>
              </h3>
            </header>
            <div class='body'>
               <p>Fever of ‚â•5 days' duration associated with at least 4* of the following 5 changes</p>
               <ol>
                <li>Bilateral nonsuppurative conjunctivitis</li>
                <li>One of more changes of the mucous membranes of the upper respiratory tract, including</li>
                <ul>
                  <li>pharyngeal injection,</li>
                  <li>dry fissured lips,</li>
                  <li>injected lips, and</li>
                  <li>‚Äústrawberry‚Äù tongue</li>
                </ul>
                <li>One or more changes of the extremities, including</li>
                <ol>
                  <li>peripheral erythema,</li>
                  <li>peripheral edema,</li>
                  <li>periungual desquamation, and</li>
                  <li>generalized desquamation</li>
                </ol>
                <li>Polymorphous rash, primarily truncal</li>
                <li>Cervical lymphadenopathy >1.5 cm in diameter</li>
               </ol>

               <p>Disease cannot be explained by some other known disease process.</p>
               <p>A diagnosis of Kawasaki disease can be made if fever and only 3 changes are present in conjunction with coronary artery disease documented by two-dimensional echocardiography or coronary angiography.</p>
            </div>
          </section>
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Treatment </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>IV immunoglobulin (IVIG) is the mainstay of therapy. A single dose of IVIG (2 g/kg over 12 hours) results in rapid defervescence and resolution of clinical illness in most patients and more importantly reduces the incidence of coronary artery aneurysms in patients with KD.</li>
            <li>Aspirin - initially given in anti-inflammatory doses (80 to 100 mg/kg/day q 6 hourly) in the acute phase.</li>
            <li>When the fever has resolved for at least 48 hours, the dose of aspirin is decreased to antithrombotic doses (3 to 5 mg/kg/day as a single dose). This dose is continued through the subacute and convalescent phases, usually for 6 to 8 weeks, until follow-up echocardiography fails to show the presence of coronary artery aneurysms.</li>
            <li>Approximately 3% to 5% of children with KD initially fail to respond satisfactorily to IVIG therapy. Most of these patients respond to retreatment with IVIG (2 g/kg over 12 hours).</li>
            <li>Corticosteroids may have a role during the acute phase if active carditis is apparent and for children with persistent fever after two doses of IVIG.</li>
           </ul>
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Complications of Kawasaki Disease </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>Coronary artery thrombosis</li>
            <li>Peripheral artery aneurysm</li>
            <li>Coronary artery aneurysms</li>
            <li>Myocardial infarction</li>
            <li>Myopericarditis</li>
            <li>Congestive heart failure</li>
            <li>Hydrops of gallbladder</li>
            <li>Aseptic meningitis</li>
            <li>Irritability</li>
            <li>Arthritis</li>
            <li>Sterile pyuria (urethritis)</li>
            <li>Thombocytosis (late)</li>
            <li>Diarrhea</li>
            <li>Pancreatitis</li>
            <li>Peripheral gangrene</li>
           </ul>
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Differential Diagnosis of Kawasaki Disease </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>Infectious</li>
            <li>Scarlet fever</li>
            <li>Epstein-Barr virus</li>
            <li>Adenovirus</li>
            <li>Meningococcemia</li>
            <li>Measles</li>
            <li>Rubella</li>
            <li>Roseola infantum</li>
            <li>Staphylococcal toxic shock syndrome</li>
            <li>Scalded skin syndrome</li>
            <li>Toxoplasmosis</li>
            <li>Leptospirosis</li>
            <li>Rocky Mountain spotted fever</li>
            <li>Inflammatory</li>
            <li>Juvenile rheumatoid arthritis (systemic onset)</li>
            <li>Polyarteritis nodosa</li>
            <li>Beh√ßet syndrome</li>
            <li>Hypersensitivity</li>
            <li>Drug reaction</li>
            <li>Stevens-Johnson syndrome (erythema multiforme)</li>
           </ul>
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'>Prognosis </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>IVIG reduces the prevalence of coronary artery disease from 20% to 25% in children treated with aspirin alone to 2% to 4% in children treated with IVIG and aspirin.</li>
            <li>Other than the risk for persistent coronary artery aneurysms, KD has an excellent prognosis.</li>
            <li>Risk factors for development of coronary artery aneurysms include</li>
            <ul>
              <li>Prolonged fever,</li>
              <li>Prolonged elevation of inflammatory parameters such as the ESR,</li>
              <li>Age younger than 1 year,</li>
              <li>Male gender.</li>
            </ul>
           </ul>
        </div>
      </section>



      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <div class="comment">
        <p>Send your comments, corrections, explanations/clarifications and requests/suggestions to our <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">WhatsApp group</a>.</p>
        </div>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this ‚ÄòWebsite‚Äô, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
